SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-159220
Filing Date
2024-06-11
Accepted
2024-06-11 17:06:34
Documents
6
Effectiveness Date
2024-06-11

Document Format Files

Seq Description Document Type Size
1 S-8 d767088ds8.htm S-8 42459
2 EX-4.4 d767088dex44.htm EX-4.4 50691
3 EX-5.1 d767088dex51.htm EX-5.1 9716
4 EX-23.2 d767088dex232.htm EX-23.2 1513
5 EX-FILING FEES d767088dexfilingfees.htm EX-FILING FEES 13855
6 GRAPHIC g767088dsp16.jpg GRAPHIC 3944
  Complete submission text file 0001193125-24-159220.txt   124912
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280126 | Film No.: 241036648
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)